Section Arrow
AQST.NASDAQ
- Aquestive Therapeutics
Quotes are at least 15-min delayed:2025/02/23 03:29 EST
Last
 3.01
-0.05 (-1.63%)
Day High 
3.15 
Prev. Close
3.06 
1-M High
3.63 
Volume 
1.42M 
Bid
3.01
Ask
3.04
Day Low
3.01 
Open
3.12 
1-M Low
2.87 
Market Cap 
279.01M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 3.14 
20-SMA 3.1 
50-SMA 3.33 
52-W High 6.23 
52-W Low 2.24 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.45/-0.50
Enterprise Value
311.91M
Balance Sheet
Book Value Per Share
-0.50
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
50.58M
Operating Revenue Per Share
0.53
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
UPCUniverse Pharmaceuticals Inc0.2003+0.0578+40.56%-- 
TLRYTilray Brands0.9452+0.0775+8.93%-- 
CGCCanopy Growth Corp1.615+0.005+0.31%-- 
TXMDTherapeuticsMD1.291+0.281+27.82%0.39PE
TEVATeva Pharmaceutical Industries Limited16.74-0.26-1.53%-- 
Quotes are at least 15-min delayed:2025/02/23 03:29 EST
Industry overview quotes are at least 15 minutes delayed
Business Description
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Sympazan Oral Film, Suboxone Sublingual Film, Exservan Oral Film, and Zuplenz. The product pipeline includes Libervant Buccal Film, AQST-108, and AQST-305. The majority of its revenue comes from the United States.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.